Archive for the ‘Medication’ Category

Blood Testing to Treat Mood Disorders

Monday, March 3rd, 2008

(Ivanhoe Newswire) — Blood testing for mood disorders may help the medical community come up with better treatments for the conditions.

Currently, there are no blood tests for mood disorders. And relying on patients to rate the severity of their symptoms and on the clinicians’ impression may limit the chances of effective treatment and new drug development.

Researchers from Indiana University School of Medicine instead propose a new way to help identify blood biomarkers to help determine mood state.

(more…)

New Treatment for Heart Arrhythmias

Monday, March 3rd, 2008

PHILADELPHIA, Pa. (Ivanhoe Newswire) — One moment you feel fine. The next, your heart is racing at almost double the pace. Atrial fibrillation affects more than two million Americans. Although it is the most common arrhythmia, medicines for the condition only work about half the time. Now, researchers are testing a new tool that may help put a patient’s heart back on track.

 

Fifty-six year old Tom Calvaresi is the driving force behind his family winery. So when his heart started feeling funny, he didn’t ignore it.

(more…)

Hand Arthritis

Friday, February 15th, 2008

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

juvenile rhuematoid arthritis knee disorders living with arthritis lupus polymyalgia rheumatica rheumatoid arthritis sjorgen syndrome: Blood disorders

Arthritis
Ciyy biofedback medicine fir arthritis i kyme disease arthritis intormation on osteoarthritis arthitis creams rhuematoid arthritis sympton, wist heumatoid arthritis flare

Arthritis: Rheumatoid Arthritis And Fatige, Arthritis Gloves
(more…)

Post Traumatic Stress Is a Risk Factor for Chronic Disease

Friday, February 15th, 2008

(Ivanhoe Newswire)  Veterans with Post Traumatic Stress Disorder (PTSD) are just as likely to have long term health problems as people with chronic disease risk factors like high white blood cell counts.  However, very few healthcare providers screen PTSD patients for these biological markers.

“Exposure to trauma has not only psychological effects, but it can take a serious toll on a person’s health status and biological function as well,” said Geisinger Health Systems Senior Investigator Joseph Boscarino, PhD, MPH.  “PTSD is a risk factor for disease that doctors should put on their radar screens.”

(more…)

Alternative Medicine And Mental Health Care

Wednesday, February 6th, 2008

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Classical Homeopathy - natural, holistic, alternative medicine Mental Health - Depression, Anxiety, PTSD, mental illness Learning and behavioral disorders, foster care

Mental Health HEALTH RESOURCES UK MASSAGE LONDON ALTERNATIVE MEDICINE
Aetna Health Care Affordable Health Care Alternative Health Alternative Medicine Animal Health Aromatherapy Canada Health Cancer Health Cat Health Centrum Multivitamin

(more…)

Abuse Worsens IBS Pain

Wednesday, February 6th, 2008

(Ivanhoe Newswire) — Women with a history of physical and/or sexual abuse may be more susceptible to the pain and suffering associated with irritable bowel syndrome (IBS).

According to researchers from UCLA and the University of North Carolina who conducted brain imaging studies on women with IBS, those with abuse in their backgrounds were less likely to be able to “turn off” a specific pain mechanism in the brain as women who also had IBS but didn’t have a history of abuse.

(more…)

Boehringer Ingelheim and Eli Lilly change Yentreve AriClaim deal

Friday, December 21st, 2007


Eli Lilly is to buy back worldwide marketing rights for Yentreve/AriClaim (duloxetine hydrochloride) from Boehringer Ingelheim. As a stress urinary incontinence (SUI) treatment, along with future related urinary incontinence indications, the drug will continue to be marketed outside the US by Lilly but other treatments using duloxetine will remain under both firms.

Lilly president and chief operating officer John Lechleiter said: “Based on our collective experiences to date in the marketplace, both companies believe that the Yentreve/AriClaim opportunity is best suited and can be best commercialised in markets outside the US with the support of one company. “This is about ‘right sizing’ our investments to address our greatest opportunities and the greatest patient needs.” Dr Alessandro Banchi, Boehringer Ingelheim chairman of the board of managing directors, added: “There has been an excellent spirit of collaboration in our alliance with Lilly.
(more…)

CALPIRG Members Speak Out on Health Care

Friday, December 21st, 2007

Health care reform is at the top of California’s agenda, and everyone agrees the system is broken. It’s harder to know which problems are the most important, and easy to lose sight of what’s really at stake in the abstract policy debates.That’s why CALPIRG recently conducted an email survey of 575 of our members, to find out what kind of reforms are most important to them, and gather their stories about the health care system.
(more…)

Rehab Programs for Doctors Face Scrutiny

Wednesday, December 19th, 2007

Recent publicity has led to increased scrutiny of confidential, state-run rehabilitation programs for physicians, the Associated Press reported Dec. 19.

An estimated 8,000 doctors with addiction problems are enrolled in treatment programs; most states have them, and California’s medical board made headlines last year when it voted to abolish its physician-assistance program after a review found that it didn’t help doctors recover and could put patients at risk.

“Patients have no way to protect themselves from these doctors,” said Julie Fellmeth, head of the University of San Diego’s Center for Public Interest Law and an opponent of the California program.

(more…)

Medtronic Sprint Fidelis Lead Defect Can Be More Of A Problem For Certain Patients

Tuesday, December 18th, 2007

People With Hypertrophic Cardiomyopathy And Those With Defibrillator-Pacemaker Dual Unit Implants May Be More In Need Of Lead Wire Replacement After Medtronic Recall

As presented in a December 13, 2007 New York Times (NYT) article, “Patients Wonder Whether to Replace a Wire That Might Fail”, for thousands of people the October 2007 Medtronic recall of its Sprint Fidelis lead wires has created confusion and doubt on various levels about what they can or should do, now:

Their defibrillators are meant to deliver electric shocks to restore normal rhythms if their hearts start beating chaotically. Should they have the potentially faulty wire, or lead, removed — or leave it in place and hope it does not fail?

(more…)